Clinical trials: Refractory Ascites
Refractory Malignant Ascites
Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites
Assessment of effectiveness, safety and local immune activation of Oncolytic Viruses H101 in patients with refractory malignant ascites.
- Trial name
- NCT04771676
- Testing
- Oncorine (H101)
- Where
- China
- Volunteers
- 25 people
- Sponsor
- Fudan University
Malignant Ascites
Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites
This study will evaluate the safety and efficacy of intraperitoneal administration of Bevacizumab to prevent the recurrence of malignant ascites.
- Trial name
- NCT02496286
- Testing
- Intraperitoneal Bevacizumab
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Eastern Regional Medical Center
Refractory Ascites, Children, Only
Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in Children
Ascites in liver cirrhosis is explained by increased production of vasoactive substances leading to renal vasoconstriction and salt and water retention.
- Trial name
- NCT04043858
- Testing
- Midodrine 2.5 mg tab
- Where
- Egypt
- Volunteers
- 20 people
- Sponsor
- National Liver Institute, Egypt
Refractory Ascites
Clinical Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patients With Refractory Cirrhotic Ascites
The aim of this clinical trial is to evaluate the safety and efficacy of low dose dapagliflozin use along with standard care versus the standard care alone in improving the clinical outcomes of patients with cirrhotic refractory…
- Trial name
- NCT06919523
- Testing
- Dapagliflozin 5mg, Standard care treatment
- Volunteers
- 70 people
- Sponsor
- Mansoura University
Refractory Ascites
Midodrine and Albumin in Patients With Refractory Ascites
Refractory ascites is seen in 5-10% of patients with cirrhosis.Decompensated cirrhosis with refractory ascites has a mortality rate of around 40% in a year and a median survival of 6 months.Portal hypertension and splanchnic…
- Trial name
- NCT04621617
- Testing
- Albumin, Midodrine, Standard medical therapy (SMT)
- Volunteers
- 114 people
- Sponsor
- Post Graduate Institute of Medical Education and Research, Chandigarh